ClinicalTrials.Veeva

Menu

Psychedelic Virtual Reality

Yale University logo

Yale University

Status

Enrolling

Conditions

Healthy Volunteer
Psychedelic Experiences
Virtual Reality

Treatments

Device: Meta Quest 3

Study type

Observational

Funder types

Other

Identifiers

NCT06581263
2000038121

Details and patient eligibility

About

The purpose of this study is to evaluate a novel VRP.

Full description

The primary objective of this study is to determine whether the subjective experience of a novel VRP (DeepDream) will be comparable to a standard dose of psychedelics. This study also looks to compare the subjective experience of DeepDream VRP to other available VR modalities developed to mimic psychedelic subjective experience along with assessing the incidence of VRP adverse effects.

Enrollment

15 estimated patients

Sex

All

Ages

21 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ability to provide informed consent
  • No history or current DSM-V diagnosis

Exclusion criteria

  • Unstable medical conditions

Trial design

15 participants in 1 patient group

Healthy Volunteer
Treatment:
Device: Meta Quest 3

Trial contacts and locations

1

Loading...

Central trial contact

Angelina Contreras; Anahita Bassir Nia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems